Injection burden 12 injections most days Best for Independent dose control Cycle driver Compound-specific phasing BPC-157 Loading 250500 mcg, daily Frequency Daily Maintenance 250 mcg, daily Route SubQ TB-500 Loading 2.05.0 mg, 2x/week Frequency 2x/week (loading), 12x/week (maintenance) Maintenance 2.0 mg, 12x/week Route SubQ Example Weekly Schedule (Loading Phase) Monday BPC-157 500 mcg SubQ + TB-500 2.5 mg SubQ Tuesday BPC-157 500 mcg SubQ Wednesday BPC-157 500 mcg SubQ Thursday BPC-157 500 mcg SubQ + TB-500 2.5 mg SubQ Friday BPC-157 500 mcg SubQ Saturday BPC-157 500 mcg SubQ Sunday BPC-157 500 mcg SubQ Use separate sterile syringes for separate-vial draws
Ethnic Factors : In individuals with darker skin tones, melanonychia may be a normal variant and not necessarily indicative of an underlying medical condition
Available at: (Accessed March 27, 2020)
Ren Q, Yang K, Zou R, Wan Z, Shen Z, Wu G, et al
This approach leverages nanomaterials to precisely modulate the molecular machinery associated with the lysosomal surface or its lumen, thereby reprogramming cellular metabolism and fate
Bnhof, G